Resources>Citations Database>Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model

Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model

Biointron 2024-06-20

Authors: Christiane Stahl-Hennig, Antonia Sophia Peter, Arne Cordsmeier, Nicole Stolte-Leeb, Ramona Vestweber, Eileen Socher, Samuel Alberto Merida, Ulrike Sauermann, Martina Bleyer, Kirsten Fraedrich, Thomas Grunwald, Thomas H. Winkler, Armin Ensser, Hans-Martin Jäck, Klaus Überla

Journal: Journal of Virology

PubMed ID: 38899895

DOI: https://doi.org/10.1128/jvi.00628-24

Products & Services: TRES6 and 4C12 were produced in CHO cells and purified by affinity chromatography (Biointron)

Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
Nov 25, 2025
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.